Key result
Childhood overweight and obesity are linked to ~48% pooled prevalence of dyslipidemia with elevated triglycerides.
Why the study?
Dyslipidemia is one of the earliest detectable cardiometabolic abnormalities in childhood overweight and obesity, yet prevalence estimates vary widely due to heterogeneity in study design and populations.
Meta-Analysis
Overweight and obese children and adolescents exhibit a high pooled prevalence of dyslipidemia (48%) and significant elevations in triglycerides and LDL cholesterol compared with normal-weight peers, supporting early standardized lipid screening.
Answers are grounded in this paper and cite their sources.
Supports early lipid screening in overweight and obese youth; extends meta-analytic evidence for cardiometabolic risk stratification in pediatrics.
Childhood overweight and obesity are increasing globally and, in India, contributing to early metabolic disturbances. Dyslipidemia is one of the earliest detectable cardiometabolic abnormalities, yet prevalence estimates vary widely due to heterogeneity in study design and populations. This study aims to determine the pooled prevalence of dyslipidemia in overweight and obese children and quantify differences in lipid parameters compared with normal-weight peers. A systematic search of PubMed, Scopus, Embase, Web of Science, Cochrane, CINAHL, and Google Scholar (2000-2024) was conducted using predefined keywords related to childhood obesity, dyslipidemia, and lipid profiles. Studies reporting prevalence or mean lipid values were included. Random-effects models were used to derive pooled prevalence and standardized mean differences (SMDs). In total, 17 studies were included in the systematic review, of which 10 were included in the meta-analysis. The pooled prevalence of dyslipidemia was 48% (95% confidence interval (CI): 13%-82%), with hypertriglyceridemia (44%) and low high-density lipoprotein (HDL) (40%) being the most frequent abnormalities. Large effect sizes were observed for triglycerides (SMD = 0.91; 95% CI: 0.51-1.32) and low-density lipoprotein cholesterol (SMD = 0.83; 95% CI: 0.07-1.59). No significant pooled difference was found for HDL (SMD = -0.11), with high heterogeneity (I² = 97.4%). This systematic review and meta-analysis provides a comprehensive synthesis of the burden of dyslipidemia among overweight, obese children and adolescents aged 2-19 years, filling a critical gap by combining prevalence data and effect-size quantification. Overweight and obese children show a substantial burden of dyslipidemia and marked lipid derangements, highlighting early cardiometabolic vulnerability. These results support standardized lipid screening and early preventive interventions in high-risk pediatric groups.
No takes yet. Share an insight, caveat, or question.
Das et al. (2026) conducted a meta-analysis in Childhood overweight and obesity with dyslipidemia. Childhood overweight and obesity vs. Normal-weight peers was evaluated on Pooled prevalence of dyslipidemia and standardized mean differences in lipid parameters (triglycerides) (SMD 0.91, 95% CI 0.51-1.32). Overweight and obese children had a 48% pooled prevalence of dyslipidemia and elevated triglycerides vs normal-weight peers.
Synapse has enriched 10 related papers. Consider them for comparative context: